NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
35.44
-0.30 (-0.84%)
At close: May 22, 2026, 4:00 PM EDT
36.60
+1.16 (3.27%)
After-hours: May 22, 2026, 4:58 PM EDT
NAMS Market Cap
NAMS has a market cap or net worth of $4.14 billion as of May 22, 2026. Its market cap has increased by 91.50% in one year.
Market Cap
4.14B
Enterprise Value
3.44B
1-Year Change
91.50%
Ranking
Category
Stock Price
$35.44
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $4.14B, an increase of 2,582.48%. That is a compound annual growth rate of 86.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 4.14B | 4.16% |
| Dec 31, 2025 | 3.98B | 44.58% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CRISPR Therapeutics AG | 4.86B |
| Dianthus Therapeutics | 4.73B |
| Ligand Pharmaceuticals | 4.60B |
| Caris Life Sciences | 4.40B |
| Veradermics | 4.19B |
| Travere Therapeutics | 4.13B |
| Crinetics Pharmaceuticals | 3.88B |
| Catalyst Pharmaceuticals | 3.83B |